Applied Immunohistochemistry and Molecular Morphology
@aimmjournal.bsky.social
Official Journal of International Society for IHC and Molecular Morphology (ISIMm), #IHCpath #Pathology Managed by @katcollmd.bsky.social
https://journals.lww.com/appliedimmunohist/pages/default.aspx
https://journals.lww.com/appliedimmunohist/pages/default.aspx
Check out our Current Issue!!
Figure from "Comparison of Gastric Signet Ring Cell Carcinoma and Adenocarcinoma From Clinicopathologic Characteristics and Protein Expressions” by Ma, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Figure from "Comparison of Gastric Signet Ring Cell Carcinoma and Adenocarcinoma From Clinicopathologic Characteristics and Protein Expressions” by Ma, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
November 10, 2025 at 1:42 AM
Check out our Current Issue!!
Figure from "Comparison of Gastric Signet Ring Cell Carcinoma and Adenocarcinoma From Clinicopathologic Characteristics and Protein Expressions” by Ma, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Figure from "Comparison of Gastric Signet Ring Cell Carcinoma and Adenocarcinoma From Clinicopathologic Characteristics and Protein Expressions” by Ma, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Join us for our Journal Club Live Webinar Series!
📚 Articles #openaccess starting Sept 23
👨🏻💻 Don't miss this opportunity to explore new research with us! #AIMMjc
Register 👉🏻 iu.zoom.us/webinar/regi...
🔗 journals.lww.com/appliedimmun...
🔗 journals.lww.com/appliedimmun...
📚 Articles #openaccess starting Sept 23
👨🏻💻 Don't miss this opportunity to explore new research with us! #AIMMjc
Register 👉🏻 iu.zoom.us/webinar/regi...
🔗 journals.lww.com/appliedimmun...
🔗 journals.lww.com/appliedimmun...
September 22, 2025 at 11:19 PM
Join us for our Journal Club Live Webinar Series!
📚 Articles #openaccess starting Sept 23
👨🏻💻 Don't miss this opportunity to explore new research with us! #AIMMjc
Register 👉🏻 iu.zoom.us/webinar/regi...
🔗 journals.lww.com/appliedimmun...
🔗 journals.lww.com/appliedimmun...
📚 Articles #openaccess starting Sept 23
👨🏻💻 Don't miss this opportunity to explore new research with us! #AIMMjc
Register 👉🏻 iu.zoom.us/webinar/regi...
🔗 journals.lww.com/appliedimmun...
🔗 journals.lww.com/appliedimmun...
Check out our Current Issue!!
Figure from "STAT6 Can Be Used in the Diagnosis of Hodgkin Lymphoma: There Are Differences in Expression Among Subtypes” by Bayçelebi, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Figure from "STAT6 Can Be Used in the Diagnosis of Hodgkin Lymphoma: There Are Differences in Expression Among Subtypes” by Bayçelebi, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
September 10, 2025 at 10:04 PM
Check out our Current Issue!!
Figure from "STAT6 Can Be Used in the Diagnosis of Hodgkin Lymphoma: There Are Differences in Expression Among Subtypes” by Bayçelebi, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Figure from "STAT6 Can Be Used in the Diagnosis of Hodgkin Lymphoma: There Are Differences in Expression Among Subtypes” by Bayçelebi, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
🚀 Join us for the launch of our Journal Club Webinar Series!
📚 Articles #openaccess starting July 28
👨🏻💻 Don't miss this opportunity to explore new research with us! #AIMMjc
Register 👉🏻 tinyurl.com/ycxeye84
🔗 journals.lww.com/appliedimmun...
🔗 journals.lww.com/appliedimmun...
📚 Articles #openaccess starting July 28
👨🏻💻 Don't miss this opportunity to explore new research with us! #AIMMjc
Register 👉🏻 tinyurl.com/ycxeye84
🔗 journals.lww.com/appliedimmun...
🔗 journals.lww.com/appliedimmun...
July 28, 2025 at 12:23 PM
🚀 Join us for the launch of our Journal Club Webinar Series!
📚 Articles #openaccess starting July 28
👨🏻💻 Don't miss this opportunity to explore new research with us! #AIMMjc
Register 👉🏻 tinyurl.com/ycxeye84
🔗 journals.lww.com/appliedimmun...
🔗 journals.lww.com/appliedimmun...
📚 Articles #openaccess starting July 28
👨🏻💻 Don't miss this opportunity to explore new research with us! #AIMMjc
Register 👉🏻 tinyurl.com/ycxeye84
🔗 journals.lww.com/appliedimmun...
🔗 journals.lww.com/appliedimmun...
Check out our Current Issue!!
Figure from "Telomerase Immunocytochemistry in Lymphocytes From Chronic Lymphocytic Leukemia” by Sučić, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Figure from "Telomerase Immunocytochemistry in Lymphocytes From Chronic Lymphocytic Leukemia” by Sučić, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
July 4, 2025 at 12:42 PM
Check out our Current Issue!!
Figure from "Telomerase Immunocytochemistry in Lymphocytes From Chronic Lymphocytic Leukemia” by Sučić, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Figure from "Telomerase Immunocytochemistry in Lymphocytes From Chronic Lymphocytic Leukemia” by Sučić, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Just published! Check out this latest article by @iamshreeya.bsky.social
🔬 Molecular subtyping of bladder cancer is essential—but not always feasible in low-resource settings
🧪 IHC markers GATA3, KRT20, KRT14, KRT5 used to stratify UCs
⚠️ Dual-negative had poorest survival (25%), luminal best (80%)
🔬 Molecular subtyping of bladder cancer is essential—but not always feasible in low-resource settings
🧪 IHC markers GATA3, KRT20, KRT14, KRT5 used to stratify UCs
⚠️ Dual-negative had poorest survival (25%), luminal best (80%)
June 15, 2025 at 12:18 AM
Just published! Check out this latest article by @iamshreeya.bsky.social
🔬 Molecular subtyping of bladder cancer is essential—but not always feasible in low-resource settings
🧪 IHC markers GATA3, KRT20, KRT14, KRT5 used to stratify UCs
⚠️ Dual-negative had poorest survival (25%), luminal best (80%)
🔬 Molecular subtyping of bladder cancer is essential—but not always feasible in low-resource settings
🧪 IHC markers GATA3, KRT20, KRT14, KRT5 used to stratify UCs
⚠️ Dual-negative had poorest survival (25%), luminal best (80%)
Just published! Check out this latest article!
🔵 PD-L1 expression showed high concordance between cores and full slides.
🔵 CD8+ T cell and CD68+ macrophage densities varied; cores underrepresented immune infiltrates.
@fabiotavora.bsky.social #IHCpath #lungcancer
🔵 PD-L1 expression showed high concordance between cores and full slides.
🔵 CD8+ T cell and CD68+ macrophage densities varied; cores underrepresented immune infiltrates.
@fabiotavora.bsky.social #IHCpath #lungcancer
June 5, 2025 at 5:12 PM
Just published! Check out this latest article!
🔵 PD-L1 expression showed high concordance between cores and full slides.
🔵 CD8+ T cell and CD68+ macrophage densities varied; cores underrepresented immune infiltrates.
@fabiotavora.bsky.social #IHCpath #lungcancer
🔵 PD-L1 expression showed high concordance between cores and full slides.
🔵 CD8+ T cell and CD68+ macrophage densities varied; cores underrepresented immune infiltrates.
@fabiotavora.bsky.social #IHCpath #lungcancer
🧬 Immunohistochemistry in Thymomas
▪️ Bcl-2 and D2-40 positivity varies across thymoma subtypes
▪️ E-cadherin is reduced in invasive tumors
▪️ β-catenin shows subtype-specific expression patterns
📊 66 resected cases analyzed
@byrk_bsr #pathsky #pathology #thymoma
▪️ Bcl-2 and D2-40 positivity varies across thymoma subtypes
▪️ E-cadherin is reduced in invasive tumors
▪️ β-catenin shows subtype-specific expression patterns
📊 66 resected cases analyzed
@byrk_bsr #pathsky #pathology #thymoma
May 20, 2025 at 1:21 AM
🧬 Immunohistochemistry in Thymomas
▪️ Bcl-2 and D2-40 positivity varies across thymoma subtypes
▪️ E-cadherin is reduced in invasive tumors
▪️ β-catenin shows subtype-specific expression patterns
📊 66 resected cases analyzed
@byrk_bsr #pathsky #pathology #thymoma
▪️ Bcl-2 and D2-40 positivity varies across thymoma subtypes
▪️ E-cadherin is reduced in invasive tumors
▪️ β-catenin shows subtype-specific expression patterns
📊 66 resected cases analyzed
@byrk_bsr #pathsky #pathology #thymoma
Telomerase Immunocytochemistry in Lymphocytes From Chronic Lymphocytic Leukemia
✨hTERT shows stronger nuclear staining in B-CLL cells vs. normal; linked to poor B-CLL prognosis #IHCpath #hemepath @katcollmd.bsky.social @ihc-guy.bsky.social
🔗 journals.lww.com/appliedimmun...
✨hTERT shows stronger nuclear staining in B-CLL cells vs. normal; linked to poor B-CLL prognosis #IHCpath #hemepath @katcollmd.bsky.social @ihc-guy.bsky.social
🔗 journals.lww.com/appliedimmun...
May 15, 2025 at 3:59 PM
Telomerase Immunocytochemistry in Lymphocytes From Chronic Lymphocytic Leukemia
✨hTERT shows stronger nuclear staining in B-CLL cells vs. normal; linked to poor B-CLL prognosis #IHCpath #hemepath @katcollmd.bsky.social @ihc-guy.bsky.social
🔗 journals.lww.com/appliedimmun...
✨hTERT shows stronger nuclear staining in B-CLL cells vs. normal; linked to poor B-CLL prognosis #IHCpath #hemepath @katcollmd.bsky.social @ihc-guy.bsky.social
🔗 journals.lww.com/appliedimmun...
Check out our Current Issue!!
Figure from "The Prevention of Fatal Tauopathy in a Mouse Model of Alzheimer Disease by Blocking BCL2” by Nuovo, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Figure from "The Prevention of Fatal Tauopathy in a Mouse Model of Alzheimer Disease by Blocking BCL2” by Nuovo, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
May 14, 2025 at 1:39 AM
Check out our Current Issue!!
Figure from "The Prevention of Fatal Tauopathy in a Mouse Model of Alzheimer Disease by Blocking BCL2” by Nuovo, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Figure from "The Prevention of Fatal Tauopathy in a Mouse Model of Alzheimer Disease by Blocking BCL2” by Nuovo, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Check out our Current Issue!!
Figure from "Claudin 18.2 Immunohistochemistry Expression in Gastric Cancer: A Systematic Review” by Lop Gros, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Figure from "Claudin 18.2 Immunohistochemistry Expression in Gastric Cancer: A Systematic Review” by Lop Gros, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
March 5, 2025 at 11:58 PM
Check out our Current Issue!!
Figure from "Claudin 18.2 Immunohistochemistry Expression in Gastric Cancer: A Systematic Review” by Lop Gros, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Figure from "Claudin 18.2 Immunohistochemistry Expression in Gastric Cancer: A Systematic Review” by Lop Gros, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Check out our Current Issue!!
Figure from "IDO1 Expression and CD8+ T-Cell Levels Are Useful Prognostic Biomarkers in Preoperative Gastric Cancer Specimens Before Neoadjuvant Chemotherapy" by Chen, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Figure from "IDO1 Expression and CD8+ T-Cell Levels Are Useful Prognostic Biomarkers in Preoperative Gastric Cancer Specimens Before Neoadjuvant Chemotherapy" by Chen, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
March 1, 2025 at 6:25 AM
Check out our Current Issue!!
Figure from "IDO1 Expression and CD8+ T-Cell Levels Are Useful Prognostic Biomarkers in Preoperative Gastric Cancer Specimens Before Neoadjuvant Chemotherapy" by Chen, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
Figure from "IDO1 Expression and CD8+ T-Cell Levels Are Useful Prognostic Biomarkers in Preoperative Gastric Cancer Specimens Before Neoadjuvant Chemotherapy" by Chen, et al.
🔗 Read the full article here: journals.lww.com/appliedimmun...
📢 Exciting news! Katrina Collins is AIMM’s new Social Media Editor! 🎉 Check out her editorial on her journey & vision—read it here: journals.lww.com/appliedimmun...
Join us in welcoming Katrina to this role! #pathsky @katcollmd.bsky.social
Join us in welcoming Katrina to this role! #pathsky @katcollmd.bsky.social
February 18, 2025 at 1:00 AM
📢 Exciting news! Katrina Collins is AIMM’s new Social Media Editor! 🎉 Check out her editorial on her journey & vision—read it here: journals.lww.com/appliedimmun...
Join us in welcoming Katrina to this role! #pathsky @katcollmd.bsky.social
Join us in welcoming Katrina to this role! #pathsky @katcollmd.bsky.social
Follow us to stay connected and up to date! #pathsky @katcollmd.bsky.social
Where to find us:
➡️ Website: journals.lww.com/appliedimmun...
➡️ Twitter: x.com/aimmjournal
➡️ Instagram: instagram.com/aimmjournal
➡️ Bluesky: bsky.app/profile/aimm...
Where to find us:
➡️ Website: journals.lww.com/appliedimmun...
➡️ Twitter: x.com/aimmjournal
➡️ Instagram: instagram.com/aimmjournal
➡️ Bluesky: bsky.app/profile/aimm...
February 17, 2025 at 11:16 PM
Follow us to stay connected and up to date! #pathsky @katcollmd.bsky.social
Where to find us:
➡️ Website: journals.lww.com/appliedimmun...
➡️ Twitter: x.com/aimmjournal
➡️ Instagram: instagram.com/aimmjournal
➡️ Bluesky: bsky.app/profile/aimm...
Where to find us:
➡️ Website: journals.lww.com/appliedimmun...
➡️ Twitter: x.com/aimmjournal
➡️ Instagram: instagram.com/aimmjournal
➡️ Bluesky: bsky.app/profile/aimm...